300
G. Barman, J. K. Ray / Tetrahedron Letters 51 (2010) 297–300
Int. Ed. 2003, 42, 2681; (g) Shiraishi, H.; Nishitani, T.; Sakaguchi, S.; Ishii, Y. J.
R1
R1
Org. Chem. 1998, 63, 6234; (h) Gorin, D. J.; Davis, N. R.; Toste, D. F. J. Am. Chem.
Soc. 2005, 127, 11260; (i) Kel’in, A. V.; Sromek, A. W.; Gevorgyan, V. J. Am. Chem.
Soc. 2001, 123, 2074; (j) Declerk, V.; Ribiere, P.; Martinez, J.; Lamaty, F. J. Org.
Chem. 2004, 69, 8372; (k) Kamijo, S.; Kanazawa, C.; Yamamoto, Y. J. Am. Chem.
Soc. 2005, 127, 9260; (l) Larionov, O. V.; de Meijere, A. Angew. Chem., Int. Ed.
2005, 44, 5664.
R2
R3
R2
R3
OH
InCl3/ ZnCl2
CH3CN
N
N
/
Ar
O
/
8. Haldar, P.; Barman, G.; Ray, J. K. Tetrahedron 2007, 63, 3049.
9. (a) Balasundaram, B.; Venugopal, M.; Perumaf, P. T. Tetrahedron Lett. 1993, 34,
4249; (b) Zaytsev, A. V.; Anderson, R. J.; Meth-Cohn, O.; Groundwater, P. W.
Tetrahedron 2005, 61, 5831.
O
Ar
9
8
Scheme 8.
10. Mahato, K. T.; Pan, D.; Mal, K. S.; Ray, J. K. J. Indian Chem. Soc. 2003, 80, 969.
11. Becher, J.; Jmgensen, P. L.; Pluta, K.; Krake, N. J.; Fat-Hansen, B. J. Org. Chem.
1992, 57, 2127–2134.
12. (a) Ray, J. K.; Kar, G. K.; Roy, B. C.; Brahma, N. K. Bioorg. Med. Chem. 1994, 2,
1417; (b) Ray, J. K.; Kar, G. K.; Adhikari, S. D.; Ray, J. K.; Brahma, N. K. Bioorg.
Med. Chem. 1998, 6, 2397–2403.
POCl3/DMF
13. General procedure for the synthesis of bisformylated pyrroles (2) and (4).
or
CHO
Ar
H
X
General procedure for the synthesis of bisformylated pyrroles (2b) from
lactam-carboxylic acids (1b).
To a flask containing DMF (5 mmol) in anhydrous CHCl3 (10 mL) at 0 °C POCl3
or PBr3 (5 mmol) was added drop by drop and the resulting mixture was stirred
for 40 min at room temp (25 °C). The reaction mixture was then cooled down
c-
PBr3/DMF
COOH
H
N
N
/
CHCl3
No reaction
/
O
Ar
to 0 °C and
a solution of c-lactam-carboxylic acids (1 mmol, 0.316 g) in
CHO
X= Cl, Br
chloroform (10 mL) was added drop-wise. The resulting reaction mixture was
refluxed at 80–90 °C for 3–8 h (monitored by TLC) and then cooled to room
temperature. The reaction mixture was then poured into ice-cold water and
solid sodium bicarbonate was carefully added to neutralize the acids and the
mixture was extracted several times (3–4 times) with 10 mL dichloromethane.
The organic part was then washed with cold water thoroughly, dried with
anhydrous sodium sulfate, and evaporated. Purification of the residue was
done by silica gel (60–120 mesh) column chromatography [petroleum ether
(60–80 °C)–ethylacetate (20:1)].
10
Scheme 9.
for decarboxylation as well as formylating reagent. These N-aryl-
bisformylated-pyrroles can be used for the synthesis of pyrrole
core bioactive products.
Physical properties and spectral data of representative compounds.
Compound 2b, 1-(4-chlorophenyl)-3-phenyl-5-bromopyrrole-2,4-dicarbalde-
hyde.
Light yellow viscous liquid, 1H NMR (CDCl3, 200 MHz) d: 7.19–7.28 (m, 2H),
7.48 (s, 6H), 7.49–7.60 (m, 1H), 9.32 (s, 1H), 9.90 (s, 1H); 13C NMR (CDCl3,
50 MHz) d: 121.09, 121.61, 128.50 (2C), 128.75, 129.11 (2C), 129.23 (2C),
129.63 (2C),130.95 (2C), 135.34, 135.95, 140.12, 178.71, 185.06. Anal. Calcd for
C18H11BrClNO2: C, 55.63; H, 2.85; N, 3.60. Found: C, 55.75; H, 3.02; N, 3.45.
Compound 4b, 1-(p-methoxy)-5-chloropyrrole-2,4-dicarbaldehyde.
Light yellow solid; mp 128–131 °C. 1H NMR (CDCl3, 200 MHz) d: 3.87 (s, 3H),
6.97–7.06 (m, 2H), 7.23–7.30 (m, 2H), 7.47 (s, 1H), 10.17 (s, 1H), 10.29 (s, 1H);
13C NMR (CDCl3, 100 MHz) d: 55.69, 114.83 (2C), 120.19, 124.37, 127.45 (2C),
127.96, 128.29, 128.60, 160.52, 185.33, 186.25. Anal. Calcd for C13H10ClNO2: C,
59.22; H, 3.82; N, 5.31. Found: C, 58.79; H, 3.68; N, 5.31.
Acknowledgments
Financial support from DST and CSIR (New Delhi) is gratefully
acknowledged.
Supplementary data
Supplementary data associated with this article can be found, in
14. Marson, C. M. Tetrahedron 1992, 48, 3659–3726.
15. (a) Haldar, P.; Ray, J. K. Tetrahedron Lett. 2008, 49, 3659–3662; (b) Barman, G.;
Roy, M.; Ray, J. K. Tetrahedron Lett. 2008, 49, 1405.
16. General procedure for the synthesis of 1,4-diphenyl-1,5-dihydro-pyrrole-2-one
derivatives (8e).
References and notes
1. (a) Sundberg, R. J.. In Comprehensive Heterocyclic Chemistry II; Katritzky, A. R.,
Rees, C. W., Scriven, E. F. V., Eds.; Elsevier: Oxford, UK, 1996; Vol. 2, p 119; (b)
O’Hagan, D. Nat. Prod. Rep. 2000, 17, 435; (c) Jendralla, H.; Baader, E.; Bartmann,
W.; Beck, G.; Bergmann, A.; Granzer, E.; Kerekjarto, B. v.; Kesseler, K.; Krause,
R.; Schubert, W.; Wess, G. J. Med. Chem. 1990, 33, 61.
2. Lee, C.-F.; Yang, L.-M.; Hwu, T.-Y.; Feng, A.-S.; Tseng, J.-C.; Luh, T.-Y. J. Am. Chem.
Soc. 2000, 122, 4992.
3. (a) Muchowski, J. M. Adv. Med. Chem. 1992, 1, 109; (b) Cozzi, P.; Mongelli, N.
Curr. Pharm. Des. 1998, 4, 181; (c) Furstner, A.; Szillat, H.; Gabor, B.; Mynott, R. J.
Am. Chem. Soc. 1998, 120, 8305.
4. Knorr, L. Chem. Ber. 1884, 17, 1635.
5. Paal, C. Chem. Ber. 1885, 18, 367.
6. Hantzsch, A. Ber. Dtsch. Chem. Ges. 1890, 23, 1474.
7. (a) Balme, G. Angew. Chem., Int. Ed. 2004, 43, 6238; (b) Nair, V.; Vinod, A. U.;
Rajesh, C. J. Org. Chem. 2001, 66, 4427; (c) Bharadwaj, A. R.; Scheidt, K. A. Org.
Lett. 2004, 6, 2465; (d) Tejedor, D.; Gonzalez-Cruz, D.; Garcia-Tellado, F.;
Marrero-Tellado, J. J.; Rodriguez, M. L. J. Am. Chem. Soc. 2004, 126, 8390; (e)
Braun, R. U.; Zietler, K.; Mu€ller, T. J. J. Org. Lett. 2001, 3, 3297; (f) Nishibayashi,
Y.; Yoshikawa, M.; Inada, Y.; Milton, M. D.; Hidai, M.; Uemura, S. Angew. Chem.,
To a flask containing 1-(3-chloro-4-fluoro-phenyl)-5-hydroxy-4-(2-thienyl)-
pyrrolidine-2-one (1 mmol, 0.3 g) in acetonitrile, (10 mL) catalytic amount of
InCl3 or ZnCl2 was added. The resulting mixture was refluxed for 6–8 h
(monitored by TLC) and then cooled to room temperature. The solvent was
evaporated under reduced pressure and the residue was extracted with 20 mL
CH2Cl2. The combined organic layer was washed with brine. After drying the
organic layer with anhydrous Na2SO4, the solvent was evaporated under
reduced pressure. The product thus obtained was purified by silica gel (60–120
mesh) column chromatography [petroleum ether (60–80 °C)–ethylacetate
(18:1)].
Compound 8e, 1-(3-chloro-4-fluoro-phenyl)-4-(2-thienyl)-1,5-dihydro-pyr-
role-2-one.
Yellow viscous liquid; 1H NMR (CDCl3, 200 MHz) d: 4.73 (d, J = 1.2 Hz, 2H), 6.32
(s, 1H), 7.03–7.15 (m, 2H), 7.19–7.35 (m, 1H), 7.49 (dd, J = 1, 5 Hz, 1H) 7.6–7.68
(m, 1H), 7.84 (dd, J = 2.6, 6.4 Hz, 1H); 13C NMR (CDCl3, 50 MHz) d: 53.05,
116.97, 117.22, 118.11, 118.24, 119.30, 120.64, 126.41, 127.13, 128.34, 134.82,
135.75, 147.70, 170.09 Anal. Calcd for C14H9ClFNOS: C, 57.24; H, 3.09; N, 4.77.
Found: C, 56.66; H, 3.30; N, 4.97.